tiprankstipranks
Ocugen: Progress in Gene Therapy and Financial Outlook
PremiumCompany AnnouncementsOcugen: Progress in Gene Therapy and Financial Outlook
12d ago
OCGN Earnings: Ocugen’s Q3 Results Disappoint
Premium
Market News
OCGN Earnings: Ocugen’s Q3 Results Disappoint
13d ago
Options Volatility and Implied Earnings Moves Today, November 08, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, November 08, 2024
13d ago
Etsy, Enphase downgraded: Wall Street’s top analyst calls
PremiumThe FlyEtsy, Enphase downgraded: Wall Street’s top analyst calls
1M ago
Maxim starts Ocugen at Buy on large addressable market sizes
Premium
The Fly
Maxim starts Ocugen at Buy on large addressable market sizes
1M ago
Ocugen initiated with a Buy at Maxim
Premium
The Fly
Ocugen initiated with a Buy at Maxim
1M ago
Ocugen announces Health Canada sent “No Objection Letter” for OCU400 trial
PremiumThe FlyOcugen announces Health Canada sent “No Objection Letter” for OCU400 trial
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
Ocugen reports Q2 EPS (4c), consensus (5c)
Premium
The Fly
Ocugen reports Q2 EPS (4c), consensus (5c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100